Key result
E/e' ratio > 13.80 linked to increased 6-month HF readmissions without affecting mortality.
Why the study?
Few studies have assessed the predictive value of the echocardiographic E/e' ratio in patients hospitalized with acute HFpEF.
Does an echocardiographic E/e’ ratio > 13.80 predict heart failure readmissions at 6 months in patients hospitalized for the first time with acute HFpEF?
Cohort (n=91)
Does an echocardiographic E/e’ ratio > 13.80 predict heart failure readmissions at 6 months in patients hospitalized for the first time with acute HFpEF?
Effect estimate: AUROC 0.693
p-value: p=0.003
An echocardiographic E/e’ ratio > 13.80 is a useful predictor of 6-month heart failure readmission in patients with a first episode of acute HFpEF.
May support short-term HF readmission risk stratification post-acute HFpEF; hypothesis-generating and requires prospective validation before practice change.
Background and Objectives: Heart failure with preserved ejection fraction (HFpEF) remains a worldwide management problem. Although there is a general effort for characterizing this population, few studies have assessed the predictive value of the echocardiographic E/e’ ratio in patients with acute HFpEF. The aim of the study was to identify groups with different prognosis in patients hospitalized with a first acute episode of HFpEF. Materials and Methods: The primary endpoint of the study was heart failure readmissions (HFR) at 6 months, while the secondary outcome was six-month mortality. We consecutively enrolled 91 patients hospitalized for the first time with acute HFpEF. We examined the E/e’ ratio as an independent predictor for HFR using univariate regression. Results: We identified and validated the E/e’ ratio as an independent predictor for HFR. An E/e’ ratio threshold value of 13.80 was calculated [(area under the receiver operating characteristic curve (AUROC) = 0.693, sensitivity = 78.60%, specificity = 55%, p < 0.004)] and validated as an inflection point for an increased number of HFR. Thus, we divided the study cohort into two groups: group 1 with an E/e’ ratio < 13.80 (n = 39) and group 2 with an E/e’ ratio > 13.80 (n = 49). Compared to group 1, group 2 had an increased number of HFR (p = 0.003) and a shorter time to first HFR (p = 0.002). However, this parameter did not influence all-cause mortality within six months (p = 0.84). Conclusions: The dimensionless E/e’ ratio is a useful discriminator between patients with acute HFpEF. An E/e’ value over 13.80 represents a simple, yet effective instrument for assessing the HFR risk. However, all-cause mortality at six months is not influenced by the E/e’ ratio.
No takes yet. Share an insight, caveat, or question.
Zamfirescu et al. (2021) conducted a cohort in Acute Heart Failure with Preserved Ejection Fraction (HFpEF) (n=91). E/e' ratio > 13.80 vs. E/e' ratio < 13.80 was evaluated on Heart failure readmissions (HFR) at 6 months (AUROC 0.693, p=0.003). An E/e' ratio > 13.80 was associated with an increased number of heart failure readmissions at 6 months compared to a ratio < 13.80 (p=0.003), but did not influence all-cause mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: